Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Stanford University
National Cancer Institute (NCI)
AstraZeneca
Genmab
Seagen Inc.
Mayo Clinic
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
STORM Therapeutics LTD
Pfizer
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Ipsen
Bristol-Myers Squibb
Kaiser Permanente
AstraZeneca
Bayer
Pfizer
Washington University School of Medicine
Radiopharm Theranostics, Ltd
Pfizer
Arvinas Inc.
Tizona Therapeutics, Inc
Boehringer Ingelheim
Aulos Bioscience, Inc.
M.D. Anderson Cancer Center
Genentech, Inc.
OHSU Knight Cancer Institute
MacroGenics
DualityBio Inc.
MacroGenics
Adaptimmune
Alliance for Clinical Trials in Oncology
Pfizer
University of California, Davis
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Novartis
Pfizer
Second Life Therapeutics
ImmunityBio, Inc.
Onchilles Pharma Inc
University Health Network, Toronto
AgonOx, Inc.